BDF
LLY icon

Balasa Dinverno & Foltz’s Eli Lilly LLY Stock Holding History

Balasa Dinverno & Foltz’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4.93M Sell
15,259
-618
-4% -$196K 0.31% 35
2022
Q2 		$5.15M Buy
15,877
+2,298
+17% +$690K 0.32% 31
2022
Q1 		$3.89M Sell
13,579
-206
-1% -$53K 0.26% 41
2021
Q4 		$3.81M Sell
13,785
-799
-5% -$203K 0.25% 40
2021
Q3 		$3.37M Buy
14,584
+1,233
+9% +$304K 0.23% 40
2021
Q2 		$3.06M Buy
+13,351
New +$2.68M 0.22% 45
2020
Q4 		– Sell
-12,719
Closed -$1.88M – 297
2020
Q3 		$1.88M Sell
12,719
-3,705
-23% -$573K 0.18% 53
2020
Q2 		$2.7M Sell
16,424
-467
-3% -$71.7K 0.3% 30
2020
Q1 		$2.34M Buy
16,891
+11,996
+245% +$1.65M 0.29% 36
2019
Q4 		$643K Sell
4,895
-438
-8% -$50.8K 0.07% 132
2019
Q3 		$596K Sell
5,333
-1,718
-24% -$191K 0.07% 131
2019
Q2 		$781K Sell
7,051
-1,007
-12% -$119K 0.09% 106
2019
Q1 		$1.05M Buy
8,058
+2,133
+36% +$259K 0.13% 74
2018
Q4 		$686K Buy
5,925
+2,296
+63% +$256K 0.09% 98
2018
Q3 		$389K Buy
3,629
+499
+16% +$49.9K 0.04% 161
2018
Q2 		$267K Buy
3,130
+65
+2% +$5.34K 0.04% 188
2018
Q1 		$237K Sell
3,065
-368
-11% -$29.6K 0.04% 192
2017
Q4 		$290K Buy
3,433
+44
+1% +$3.74K 0.04% 173
2017
Q3 		$290K Buy
3,389
+38
+1% +$3.12K 0.05% 167
2017
Q2 		$276K Buy
3,351
+6
+0.2% +$490 0.04% 170
2017
Q1 		$281K Buy
3,345
+206
+7% +$16.5K 0.05% 165
2016
Q4 		$231K Buy
3,139
+122
+4% +$9.09K 0.04% 169
2016
Q3 		$242K Hold
3,017
– – 0.04% 157
2016
Q2 		$238K Sell
3,017
-481
-14% -$36.2K 0.04% 155
2016
Q1 		$252K Sell
3,498
-500
-13% -$37.8K 0.05% 147
2015
Q4 		$337K Hold
3,998
– – 0.06% 137
2015
Q3 		$335K Buy
3,998
+314
+9% +$26.5K 0.06% 122
2015
Q2 		$308K Sell
3,684
-3
-0.1% -$229 0.05% 140
2015
Q1 		$268K Buy
3,687
+193
+6% +$13.7K 0.04% 159
2014
Q4 		$241K Buy
3,494
+320
+10% +$21.6K 0.03% 166
2014
Q3 		$206K Buy
+3,174
New +$201K 0.03% 173

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Balasa Dinverno & Foltz's LLY Position: Q3 2022 in Review

Balasa Dinverno & Foltz reduced its Eli Lilly (LLY) stake by 3.9% in Q3 2022, selling an estimated $196K and leaving 15,259 shares worth $4.93M. The position accounts for 0.31% of the portfolio, ranked #35.

Balasa Dinverno & Foltz first reported a position in LLY in Q3 2014 and has held it in 31 quarters since. The position peaked at $5.15M in Q2 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Balasa Dinverno & Foltz held 15,259 shares of Eli Lilly worth $4.93M as of Q3 2022.
  • Balasa Dinverno & Foltz sold 618 Eli Lilly shares in Q3 2022, an estimated $196K.
  • Eli Lilly made up 0.31% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #35 holding.
  • Balasa Dinverno & Foltz first reported a position in Eli Lilly in Q3 2014 and has held it in 31 quarters since.
  • Balasa Dinverno & Foltz's Eli Lilly position peaked at $5.15M in Q2 2022.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.